Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
There is no human timeline because the combined blend has not undergone human trials
doi: 10.1080/00325481.2021.2002616
Cc yu t ny khin gan d tch t lipid, tng vim v tn thng t bo
Downregulation of ASS1 caused by promoter methylation increases the susceptibility of tumor cells to PEGylated arginine deiminase (ADI-PEG20) (Table 1), a drug for arginine-deprivation treatment that has been used in clinical trials for a variety of tumors (Delage et al., 2012
US$ 25.04
US$ 24.68
US$ 24.61
US$ 21.50
US$ 28.95
US$ 29.57
US$ 29.44
